Anika Therapeutics, Inc. Quarterly Other Assets, Noncurrent in USD from Q4 2016 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Anika Therapeutics, Inc. quarterly Other Assets, Noncurrent history and growth rate from Q4 2016 to Q2 2024.
  • Anika Therapeutics, Inc. Other Assets, Noncurrent for the quarter ending June 30, 2024 was $19.5M, a 0.69% increase year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $19.5M +$134K +0.69% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $17.6M -$560K -3.09% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $18.7M +$1.45M +8.44% Dec 31, 2023 10-Q 2024-08-08
Q3 2023 $19M +$609K +3.32% Sep 30, 2023 10-Q 2023-11-03
Q2 2023 $19.4M -$1.52M -7.29% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $18.1M -$2.25M -11.1% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $17.2M -$3.07M -15.1% Dec 31, 2022 10-K 2024-03-15
Q3 2022 $18.3M -$5.33M -22.5% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $20.9M +$2.17M +11.6% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $20.4M +$93K +0.46% Mar 31, 2022 10-Q 2022-05-06
Q4 2021 $20.3M +$4.87M +31.6% Dec 31, 2021 10-K 2023-03-16
Q3 2021 $23.7M +$10.4M +79% Sep 30, 2021 10-Q 2021-11-05
Q2 2021 $18.7M +$5.3M +39.4% Jun 30, 2021 10-Q 2021-08-06
Q1 2021 $20.3M -$7.22M -26.2% Mar 31, 2021 10-Q 2021-05-07
Q4 2020 $15.4M +$7.94M +106% Dec 31, 2020 10-K 2022-03-11
Q3 2020 $13.2M +$7.47M +130% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $13.5M +$8.57M +175% Jun 30, 2020 10-Q 2020-08-07
Q1 2020 $27.5M +$23.5M +587% Mar 31, 2020 10-Q 2020-05-22
Q4 2019 $7.48M +$2.58M +52.7% Dec 31, 2019 10-K/A 2021-04-26
Q3 2019 $5.76M +$4.65M +419% Sep 30, 2019 10-Q 2019-10-28
Q2 2019 $4.88M +$3.73M +322% Jun 30, 2019 10-Q 2019-07-26
Q1 2019 $4M +$2.76M +221% Mar 31, 2019 10-Q 2019-05-06
Q4 2018 $4.9M +$3.64M +291% Dec 31, 2018 10-K 2020-03-06
Q3 2018 $1.11M -$174K -13.6% Sep 30, 2018 10-Q 2018-10-26
Q2 2018 $1.16M Jun 30, 2018 10-Q 2018-07-31
Q1 2018 $1.25M Mar 31, 2018 10-Q 2018-05-10
Q4 2017 $1.25M +$1.19M +1717% Dec 31, 2017 10-K 2019-02-27
Q3 2017 $1.28M Sep 30, 2017 10-Q 2017-10-27
Q4 2016 $69K Dec 31, 2016 10-K 2018-02-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.